Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Mitral valve

Percutaneous Repair of Paravalvular Leaks After TAVR: The Challenge of Identifying Eligible Subjects

Courtesy of Dr. Carlos Fava. This study enrolled 72 patients who underwent transcatheter aortic valve replacement with an Edwards Sapiens valve,...
solaci -
Learn More
Structural heart disease

MANTA Closure Device for large-bore arteriotomy closure: Is It Safe?

 Courtesy of Dr. Agustín Vecchia.  The number of transcatheter aortic valve replacements (TAVR) and the placement of aortic endoprosthesis and...
solaci -
Learn More
Structural heart disease

TAVI Frailty Indices: We Should Start Using Them

Courtesy of Dr. Carlos Fava. Frailty should be taken into account when deciding transcatheter aortic valve implantation (TAVI)....
solaci -
Learn More
Structural heart disease

Pacing with a 0.035” Guidewire, an Old Technique Coming Back to Simplify TAVR

This study seeks to prove the safety and efficacy of rapid left ventricular pacing through a 0.035”...
solaci -
Learn More
Mitral valve

MitraClip: Impact of Sinus Rhythm and Heart Rate

Courtesy of Dr. Carlos Fava. Atrial fibrillation (AF) and fast heart rate (>70 lpm) have been shown to...
solaci -
Learn More
Structural heart disease

Cerebral Protection in TAVR: Does It Improve Cognitive Function?

Neurological complications during transcatheter aortic valve replacement (TAVR) may be reduced with cerebral protection devices; this study...
solaci -
Learn More
Structural heart disease

Meta-analysis on Cerebral Embolic Protection in TAVR

Cerebral embolic protection is a strategy to prevent embolization of thrombotic or calcific debris during transcatheter aortic...
solaci -
Learn More
Structural heart disease

Evolut R: Clinical Results Might Be Better than Those for First-Generation CoreValve

Two recent articles featured in  JACC Cardiovascular Interventions  showed that short term (at 30 days) outcomes of patients...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

AHA 2024 | VANISH2 Trial

Dr. Omar Tupayachi - 0
Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

Dr. Omar Tupayachi - 0
It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Dr. Omar Tupayachi - 0
Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy